6-8
Oct
2026
Piramal Pharma Solutions
About Piramal Pharma Solutions
Certifications
-
GMP
Categories
Meet us at
-
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
-
Country/Region:United States
-
On CPHI since:2017
-
Certificates:1
-
Employees:5000+
Company types
Primary activities
Contact info
-
-
-
18655 Krause Street, Riverview MI , 48193, Michigan, United States
Piramal Pharma Solutions Resources (15)
-
News Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites
Addition of commercial-scale sterile injectables capabilities in Lexington, KY-Addition of development and commercial-scale capabilities in payload-linkers for bioconjugates in Riverview, MI-This is incremental to Piramal’s prior investments of $570 M in the US.
-
Brochure How Our Lexington Site Expansion Benefits Patients
Stu Needleman, Chief Commercial Officer and Chief Patient Centricity Officer of Piramal Pharma Solutions, discusses the vision behind this expansion -
Brochure Piramal Pharma announces $90M Expansion Plan for Sterile Injectables Facility in
$85M investment plan will add commercial scale sterile injectables capabilities. Expansion will significantly increase production capacity -
Brochure 6 Reasons to Partner with Piramal Aurora on APIs
Piramal Pharma Solutions' Aurora facility excels in the process/route selection, process development, and cGMP and non-GMP manufacturing of APIs. With extensive -
Brochure Breaking Ground on Our $90 Million Sterile Injectable Facility Expansion
On June 25, 2025, Piramal Pharma Solutions officially broke ground on a major expansion at our Sterile Injectable facility in Lexington, Kentucky. -
Brochure Piramal Pharma announces $85M Expansion Plan for Sterile Injectables Facility in
$90M investment plan will add commercial scale sterile injectables capabilities. Expansion will significantly increase production capacity -
Brochure Global Capabilities Brochure
Explore our global network of sites and capabilities designed to support your molecule from discovery through commercialization -
Brochure ADCelerate, Rapid, Integration ADC to IND
ADCelerate is Piramal Pharma Solutions’ rapid approach to delivering Phase-I appropriate ADC drug substance and drug product -
Brochure ADC_Quick_Facts_Sheet
ADCelerate Quick Facts Sheet -
Brochure Antibody Drug Conjugate Services
Explore our integrated ADC development and manufacturing services, designed to take your molecule from concept to clinic with speed and precision. -
Brochure Generic Peptide APIs Peptides for Toxicology & Clinical Trials
Generic Peptide APIs Peptides for Toxicology & Clinical Trials -
Brochure Yapan_Vaccines_and_Biologics_Quick_Facts_Sheet
Vaccines_and_Biologics_Quick_Facts_Sheet -
Brochure Piramal Pharma Solutions Global Site Capabilities
We provide development and manufacturing of API and HPAPI across our facilities spread across North America, Europe and Asia -
Brochure Piramal Pharma Solutions Global Site Capabilities
Global Capabilities Sheet